Nasser Khaled Altorki

Dr. Nasser Khaled Altorki is a Professor of Cardiothoracic Surgery and the Director of the Division of Thoracic Surgery at NewYork Presbyterian-Weill Cornell Medical Center. He is an internationally renowned thoracic surgeon specializing in minimally invasive lung and esophageal surgery, treating complex conditions including lung cancer, esophageal cancer, and various benign chest diseases.

Dr. Altorki earned his medical degree (M.B., B.Ch.) from the University of Cairo, Faculty of Medicine in 1977. He completed his general surgery residency at the University of Chicago Hospital, followed by a fellowship in Thoracic and Cardiovascular Surgery at the same institution. His professional journey has led him to become a leading figure in thoracic surgical oncology.

Dr. Altorki's research focuses on cutting-edge approaches to thoracic malignancies and esophageal diseases. His primary interests include lung cancer immunotherapy and prevention, esophageal diseases including gastroesophageal reflux and esophageal motor disorders, the biology and treatment of esophageal carcinoma, mediastinal tumors, thymomas, and clinical trials in lung and esophageal cancer. He is particularly passionate about bringing the latest advances in minimally invasive surgery, immunotherapy, and precision medicine to his patients. His clinical expertise encompasses a comprehensive range of thoracic procedures from robotic-assisted thymectomy to complex esophageal resections for cancer.

Analysis of Dr. Altorki's extensive publication record reveals a strong focus on advancing lung cancer treatment through innovative surgical techniques, immunotherapy combinations, and precision medicine approaches. His work spans clinical trials evaluating new treatment protocols, investigations into the molecular mechanisms of cancer progression, and studies examining disparities in cancer care delivery. A significant portion of his recent research examines the optimal surgical approaches for early-stage lung cancer and the integration of immunotherapy into multimodal treatment regimens, with numerous publications in top journals like The Journal of Thoracic and Cardiovascular Surgery and Nature Communications.

• Honor Society, Cairo University (1977)
• American Cancer Society Award and Fellowship (1983-84)
• Rated one of New York Magazine's Best Doctors

As Director of the Division of Thoracic Surgery at NewYork Presbyterian-Weill Cornell Medical Center, Dr. Altorki leads a multidisciplinary team focused on advancing thoracic surgical care and research. His external collaborations include relationships with Angiocrine Bioscience, Inc., TMRW, and Viewpoint medical, as well as professional relationships with pharmaceutical companies including F. Hoffmann-La Roche AG, Medtronic, Merck Sharp & Dohme LLC, and Regeneron Pharmaceuticals. His clinical practice at 525 East 68th Street, New York, accepts new patients and offers video visits for consultations.